Progressive supranuclear palsy (PSP) is a neurodegenerative syndrome that is clinically characterized by progressive postural instability, supranuclear gaze palsy, parkinsonism and cognitive decline. Pathologically, diagnosis of PSP is based on characteristic features, such as neurofibrillary tangles, neutrophil threads, tau-positive astrocytes and their processes in basal ganglia and brainstem, and the accumulation of 4 repeat tau protein. PSP is generally recognized as a sporadic disorder; however, understanding of genetic background of PSP has been expanding rapidly. Here we review relevant publications to outline the genetics of PSP. Although only small number of familial PSP cases have been reported, the recognition of familial PSP has been increasing. In some familial cases of clinically probable PSP, PSP pathologies were confirmed based on NINDS neuropathological diagnostic criteria. Several mutations in MAPT, the gene that causes a form of familial frontotemporal lobar degeneration with tauopathy, have been identified in both sporadic and familial PSP cases. The H1 haplotype of MAPT is a risk haplotype for PSP, and within H1, a sub-haplotype (H1c) is associated with PSP. A recent genome-wide association study on autopsyproven PSP revealed additional PSP risk alleles in STX6 and EIF2AK3. Several heredodegenerative parkinsonian disorders are referred to as PSP-look-alikes because their clinical phenotype, but not their pathology, mimics PSP. Due to the fast development of genomics and bioinformatics, more genetic factors related to PSP are expected to be discovered. Undoubtedly, these studies will provide a better understanding of the pathogenesis of PSP and clues for developing therapeutic strategies.
Citations
Citations to this article as recorded by
Myelin basic protein and TREM2 quantification in the CSF of patients with Multiple System Atrophy and other Parkinsonian conditions Fabian Maass, Sezgi Canaslan, Christoph van Riesen, Peter Hermann, Matthias Schmitz, Claudia Schulte, Kathrin Brockmann, Matthis Synofzik, Mathias Bähr, Inga Zerr Journal of Neurology.2025;[Epub] CrossRef
Identification of Genetic Variants in Progressive Supranuclear Palsy in Southeast Asia Adeline Su Lyn Ng, Ai Huey Tan, Yi Jayne Tan, Jia Lun Lim, Michelle Mulan Lian, Alfand Marl Dy Closas, Azlina Ahmad‐Annuar, Shanthi Viswanathan, Yuen Kang Chia, Jia Nee Foo, Weng Khong Lim, Eng‐King Tan, Shen‐Yang Lim Movement Disorders.2024; 39(10): 1829. CrossRef
Recent advances in stem cell therapy: efficacy, ethics, safety concerns, and future directions focusing on neurodegenerative disorders – a review Rekha Khandia, Pankaj Gurjar, Priyanka, Victoria Romashchenko, Sami A. Al-Hussain, Magdi E.A. Zaki International Journal of Surgery.2024; 110(10): 6367. CrossRef
Genetic Architecture of Primary Tauopathies Daniel Gallo, Agustín Ruiz, Pascual Sánchez-Juan Neuroscience.2023; 518: 27. CrossRef
Direct and Indirect Effects of Filamin A on Tau Pathology in Neuronal Cells Stéphanie Levert, Julie Pilliod, Étienne Aumont, Sandrine Armanville, Cyntia Tremblay, Frédéric Calon, Nicole Leclerc Molecular Neurobiology.2023; 60(2): 1021. CrossRef
Identification of phosphorylated tau protein interactors in progressive supranuclear palsy (PSP) reveals networks involved in protein degradation, stress response, cytoskeletal dynamics, metabolic processes, and neurotransmission Rowan A. W. Radford, Stephanie L. Rayner, Paulina Szwaja, Marco Morsch, Flora Cheng, Tianyi Zhu, Jocelyn Widagdo, Victor Anggono, Dean L. Pountney, Roger Chung, Albert Lee Journal of Neurochemistry.2023; 165(4): 563. CrossRef
Pathomechanisms of cognitive impairment in progressive supranuclear palsy Kurt A. Jellinger Journal of Neural Transmission.2023; 130(4): 481. CrossRef
Differential Diagnosis of Rare Subtypes of Progressive Supranuclear Palsy and PSP-Like Syndromes—Infrequent Manifestations of the Most Common Form of Atypical Parkinsonism Patrycja Krzosek, Natalia Madetko, Anna Migda, Bartosz Migda, Dominika Jaguś, Piotr Alster Frontiers in Aging Neuroscience.2022;[Epub] CrossRef
Characterisation of the Function of a SINE-VNTR-Alu Retrotransposon to Modulate Isoform Expression at the MAPT Locus Alexander Fröhlich, Abigail L. Pfaff, Vivien J. Bubb, Sulev Koks, John P. Quinn Frontiers in Molecular Neuroscience.2022;[Epub] CrossRef
Case of a Man with Hemichorea and Behavioral Changes: “A Red Herring” Galit Kleiner, Stephen A. Ryan, Juan Bilbao, Julia Keith, Ekaterina Rogaeva, Sandra E. Black, Anthony E. Lang, Mario Masellis Movement Disorders Clinical Practice.2022; 9(4): 501. CrossRef
MAPT gene mutation in familiar progressive supranuclear palsy, a case report M. Rodríguez, H. Kreinter, N. Zapa, O. Oliveros, C. Jiménez Neurology Perspectives.2022; 2(3): 184. CrossRef
Investigational therapeutics for the treatment of progressive supranuclear palsy David G Coughlin, Irene Litvan Expert Opinion on Investigational Drugs.2022; 31(8): 813. CrossRef
Mass spectrometry‐based proteomics analysis of human globus pallidus from progressive supranuclear palsy patients discovers multiple disease pathways Yura Jang, Thujitha Thuraisamy, Javier Redding‐Ochoa, Olga Pletnikova, Juan C. Troncoso, Zhen Zhang, Liana S. Rosenthal, Ted M. Dawson, Alexander Y. Pantelyat, Chan Hyun Na Clinical and Translational Medicine.2022;[Epub] CrossRef
Reference SVA insertion polymorphisms are associated with Parkinson’s Disease progression and differential gene expression Abigail L. Pfaff, Vivien J. Bubb, John P. Quinn, Sulev Koks npj Parkinson's Disease.2021;[Epub] CrossRef
Cellular and pathological heterogeneity of primary tauopathies Dah-eun Chloe Chung, Shanu Roemer, Leonard Petrucelli, Dennis W. Dickson Molecular Neurodegeneration.2021;[Epub] CrossRef
Tau and MAPT genetics in tauopathies and synucleinopathies Etienne Leveille, Owen A. Ross, Ziv Gan-Or Parkinsonism & Related Disorders.2021; 90: 142. CrossRef
Optimizing intracellular antibodies (intrabodies/nanobodies) to treat neurodegenerative disorders Anne Messer, David C. Butler Neurobiology of Disease.2020; 134: 104619. CrossRef
Heavy metals contaminating the environment of a progressive supranuclear palsy cluster induce tau accumulation and cell death in cultured neurons Carolina Alquezar, Jessica B. Felix, Elizabeth McCandlish, Brian T. Buckley, Dominique Caparros-Lefebvre, Celeste M. Karch, Lawrence I. Golbe, Aimee W. Kao Scientific Reports.2020;[Epub] CrossRef
LRP10 variants in progressive supranuclear palsy Leonie J.M. Vergouw, Shamiram Melhem, Laura Donker Kaat, Wang Z. Chiu, Demy J.S. Kuipers, Guido Breedveld, Agnita J.W. Boon, Li-San Wang, Adam C. Naj, Elizabeth Mlynarksi, Laura Cantwell, Marialuisa Quadri, Owen A. Ross, Dennis W. Dickson, Gerard D. Schel Neurobiology of Aging.2020;[Epub] CrossRef
Neuro-ophthalmology in the Geriatric Eye Subhan Tabba, Yi-Hsien Yeh, Ashwini Kini, Bayan Al Othman, Andrew G Lee US Ophthalmic Review.2020; 13(1): 30. CrossRef
Genetic Risk Factors for Essential Tremor: A Review Vasileios Siokas, Athina-Maria Aloizou, Zisis Tsouris, Ioannis Liampas, Paraskevi Aslanidou, Metaxia Dastamani, Alexandros G. Brotis, Dimitrios P. Bogdanos, Georgios M. Hadjigeorgiou, Efthimios Dardiotis Tremor and Other Hyperkinetic Movements.2020; 10: 4. CrossRef
PSP-FTD Complex: A Possible Variant of PSP Sunil Pradhan, Ruchika Tandon American Journal of Alzheimer's Disease & Other Dementias®.2020;[Epub] CrossRef
Microglial Activation and Inflammation as a Factor in the Pathogenesis of Progressive Supranuclear Palsy (PSP) Piotr Alster, Natalia Madetko, Dariusz Koziorowski, Andrzej Friedman Frontiers in Neuroscience.2020;[Epub] CrossRef
Tau at the interface between neurodegeneration and neuroinflammation Alessandro Didonna Genes & Immunity.2020; 21(5): 288. CrossRef
Efficiency of Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy: Estimation Using Goniometry and Dinamometry K. A. Major, Z. Zs. Major, R. Craciunas, G. Carbone, C. Vaida, D. L. Pîslă Neurophysiology.2019; 51(1): 57. CrossRef
Four-repeat tauopathies Thomas W. Rösler, Amir Tayaranian Marvian, Matthias Brendel, Niko-Petteri Nykänen, Matthias Höllerhage, Sigrid C. Schwarz, Franziska Hopfner, Thomas Koeglsperger, Gesine Respondek, Kerstin Schweyer, Johannes Levin, Victor L. Villemagne, Henryk Barthel, Os Progress in Neurobiology.2019; 180: 101644. CrossRef
One decade ago, one decade ahead in progressive supranuclear palsy Maria Stamelou, Nikolaos Giagkou, Günter U Höglinger Movement Disorders.2019; 34(9): 1284. CrossRef
The genetic and clinico‐pathological profile of early‐onset progressive supranuclear palsy Edwin Jabbari, John Woodside, Manuela M.X. Tan, Nicola Pavese, Oliver Bandmann, Boyd C.P. Ghosh, Luke A. Massey, Erica Capps, Tom T. Warner, Andrew J. Lees, Tamas Revesz, Janice L. Holton, Nigel M. Williams, Donald G. Grosset, Huw R. Morris Movement Disorders.2019; 34(9): 1307. CrossRef
Tau-Induced Pathology in Epilepsy and Dementia: Notions from Patients and Animal Models Marina Sánchez, Ana García-Cabrero, Gentzane Sánchez-Elexpuru, Daniel Burgos, José Serratosa International Journal of Molecular Sciences.2018; 19(4): 1092. CrossRef
Replication of progressive supranuclear palsy genome-wide association study identifies SLCO1A2 and DUSP10 as new susceptibility loci Monica Y. Sanchez-Contreras, Naomi Kouri, Casey N. Cook, Daniel J. Serie, Michael G. Heckman, NiCole A. Finch, Richard J. Caselli, Ryan J. Uitti, Zbigniew K. Wszolek, Neill Graff-Radford, Leonard Petrucelli, Li-San Wang, Gerard D. Schellenberg, Dennis W. Molecular Neurodegeneration.2018;[Epub] CrossRef
Improving Mouse Models for Dementia. Are All the Effects in Tau Mouse Models Due to Overexpression? Zelah Joel, Pablo Izquierdo, Dervis A. Salih, Jill C. Richardson, Damian M. Cummings, Frances A. Edwards Cold Spring Harbor Symposia on Quantitative Biology.2018; 83: 151. CrossRef
Clinical heterogeneity of progressive supranuclear palsy Alexey A. Tappakhov, Tatiana E. Popova, Tatiana G. Govorova, Alyona Yu. Petrova Annals of Clinical and Experimental Neurology.2018; 12(2): 33. CrossRef
Clinical heterogeneity of progressive supranuclear palsy Alexey A. Tappakhov, Tatiana E. Popova, Tatiana G. Govorova, Alyona Yu. Petrova Annals of Clinical and Experimental Neurology.2018; 12(2): 33. CrossRef
Signature of an aggregation-prone conformation of tau Neil A. Eschmann, Elka R. Georgieva, Pritam Ganguly, Peter P. Borbat, Maxime D. Rappaport, Yasar Akdogan, Jack H. Freed, Joan-Emma Shea, Songi Han Scientific Reports.2017;[Epub] CrossRef
Chronic traumatic encephalopathy-integration of canonical traumatic brain injury secondary injury mechanisms with tau pathology Jacqueline R. Kulbe, Edward D. Hall Progress in Neurobiology.2017; 158: 15. CrossRef
MAPT mutation associated with frontotemporal dementia and parkinsonism (FTDP-17) Robert Haussmann, Marek Wysocki, Moritz D. Brandt, Andreas Hermann, Markus Donix International Psychogeriatrics.2017; 29(5): 869. CrossRef
Progressieve supranucleaire parese Peter van Domburg Neuropraxis.2016; 20(2): 68. CrossRef
Gene expression, methylation and neuropathology correlations at progressive supranuclear palsy risk loci Mariet Allen, Jeremy D. Burgess, Travis Ballard, Daniel Serie, Xue Wang, Curtis S. Younkin, Zhifu Sun, Naomi Kouri, Saurabh Baheti, Chen Wang, Minerva M. Carrasquillo, Thuy Nguyen, Sarah Lincoln, Kimberly Malphrus, Melissa Murray, Todd E. Golde, Nathan D. Acta Neuropathologica.2016; 132(2): 197. CrossRef
Current status of biomarker research in neurology Jiri Polivka, Jiri Polivka, Kristyna Krakorova, Marek Peterka, Ondrej Topolcan EPMA Journal.2016;[Epub] CrossRef
Genetic and Transcriptomic Profiles of Inflammation in Neurodegenerative Diseases: Alzheimer, Parkinson, Creutzfeldt-Jakob and Tauopathies Irene López González, Paula Garcia-Esparcia, Franc Llorens, Isidre Ferrer International Journal of Molecular Sciences.2016; 17(2): 206. CrossRef
Genetic Disorders with Tau Pathology: A Review of the Literature and Report of Two Patients with Tauopathy and Positive Family Histories Pawel Tacik, Monica Sanchez-Contreras, Rosa Rademakers, Dennis W. Dickson, Zbigniew K. Wszolek Neurodegenerative Diseases.2016; 16(1-2): 12. CrossRef